CAS RN: 1364699-31-9
4-(1-(3-Bromophenyl)ethyl)morpholine
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1364699-31-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1364699-31-9 / 4-[1-(3-bromophenyl)ethyl]morpholine
Standard CAS: 1364699-31-9
Multi CAS: No
Basic Information
copy
CAS
1364699-31-9 copy
Multi CAS
No copy
Molecular Formula
C12H16BrNO copy
Molecular Weight
270.170000 copy
Exact Mass
269.041530 copy
SMILES
CC(C1=CC(=CC=C1)Br)N2CCOCC2 copy
InChI
InChI=1S/C12H16BrNO/c1-10(14-5-7-15-8-6-14)11-3-2-4-12(13)9-11/h2-4,9-10H,5-8H2,1H3 copy
InChIKey
KDWFLFIFJDRZLP-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.5 copy
Rotatable bonds
2 copy
H-bond acceptors
2 copy
Molar refractivity
64.95 copy
TPSA
12.47 copy
LogP / Solubility
WLOGP
2.84 copy
MLOGP
2.51 copy
XLogP3
2.5 copy
Consensus LogP
2.62 copy
Log S (ESOL)
-3.47 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.83 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-4.02 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.35 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
2 copy